Celesio Plans to Sell DocMorris Pharmacy Business, FAZ Reports

Celesio AG (CLS1) plans to sell its DocMorris mail-order pharmacy business, Frankfurter Allgemeine Zeitung reported, without saying where it got the information.

Celesio has hired Deutsche Bank AG (DBK) to seek potential buyers, FAZ reported in an e-mailed preview of a story to be published tomorrow. The sale is scheduled to be completed this year, and the unit may bring a price of more than 100 million euros ($133.2 million), the newspaper reported.

Rainer Berghausen, a Celesio spokesman, declined to comment by telephone today.

To contact the reporter on this story: Naomi Kresge in Berlin at nkresge@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.